Information Collection: Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations Other Than Conventional Residences Receiving Such Patients, 55879-55880 [2015-23367]

Download as PDF Federal Register / Vol. 80, No. 180 / Thursday, September 17, 2015 / Notices For additional direction on accessing information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Yiu Law, Office of New Reactors, telephone: 301–415–0523, email: Yiu.Law@nrc.gov or Edward O’Donnell, Office of Nuclear Regulatory Research, telephone: 301– 415–3317, email: Edward.ODonnell@ nrc.gov. Both are staff of the U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2015– 0220 when contacting the NRC about the availability of information regarding this document. You may obtain pubically-available information related to this document by the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2015–0220. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The DG is electronically available in ADAMS under Accession No. ML15061A048. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. tkelley on DSK3SPTVN1PROD with NOTICES B. Submitting Comments Please include Docket ID NRC–2015– 0220 in the subject line of your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enters the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. VerDate Sep<11>2014 17:30 Sep 16, 2015 Jkt 235001 If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submissions. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Additional Information The NRC is issuing for public comment a DG in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public such information as methods that are acceptable to the NRC staff for implementing specific parts of the NRC’s regulations, techniques that the staff uses in evaluating specific issues or postulated events, and data that the staff needs in its review of applications for permits and licenses. The DG, entitled, ‘‘Seismic Design Classification for Nuclear Power Plants,’’ is temporarily identified by its task number, DG–1315. DG–1315 is proposed revision 5 of RG 1.29. The guide describes a method that the staff of the NRC considers acceptable for use in identifying and classifying those features of LWR nuclear power plants that must be designed to withstand the effects of the SSE. This DG does not present new regulatory requirements, but is intended to clarify content in Section C, ‘‘Staff Regulatory Guidance,’’ by (1) addition of a reference to the definition of the reactor coolant pressure boundary in section 50.2 of Title 10 of the Code of Federal Regulations (CFR), and (2) a reorganization of systems and subsystems to add clarity to the staff guidance. It also adds a reference to a related international standard, and it was reformatted to align with current program guidance for regulatory guides. III. Backfitting and Issue Finality DG–1315 describes a method that the staff of the NRC considers acceptable for use in identifying and classifying those features of LWR nuclear power plants that must be designed to withstand the effects of the SSE. Issuance of this DG, if finalized, would not constitute backfitting as defined in 10 CFR 50.109 (the Backfit Rule) and would not otherwise be inconsistent with the issue finality provisions in 10 CFR part 52. As discussed in the ‘‘Implementation’’ section of this DG, the NRC has no current intention to impose this guided, PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 55879 if finalized, on holders of current operating licenses or combined licenses. This DG may be applied to applications for operating licenses, combined licenses, early site permits, and certified design rules docketed by the NRC as of the date of issuance of the final regulatory guide, as well as future applications submitted after the issuance of the regulatory guide. Such action would not constitute backfitting as defined in the Backfit Rule or be otherwise inconsistent with the applicable issue finality provision in 10 CFR part 52, inasmuch as such applicants or potential applicants are not within the scope of entities protected by the Backfit Rule or the relevant issue finality provisions in part 52. Dated at Rockville, Maryland, this 14th day of September, 2015. For the Nuclear Regulatory Commission. Thomas H. Boyce, Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2015–23365 Filed 9–16–15; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2015–0102] Information Collection: Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations Other Than Conventional Residences Receiving Such Patients Nuclear Regulatory Commission. ACTION: Proposed information collection: request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a proposed collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ‘‘Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than Conventional Residences Receiving Such Patients.’’ DATES: Submit comments by October 19, 2015. ADDRESSES: Submit comments directly to OMB reviewer at: Vlad Dorjets, Desk Officer, Office of Information and Regulatory Affairs (3150–XXXX), NEOB–10202, Office of Management and Budget, Washington, DC 20503; SUMMARY: E:\FR\FM\17SEN1.SGM 17SEN1 55880 Federal Register / Vol. 80, No. 180 / Thursday, September 17, 2015 / Notices telephone: 202–395–7315, email: oira_ submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of Information Services, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–6258; email: INFOCOLLECTS.Resource@NRC.GOV. SUPPLEMENTARY INFORMATION: tkelley on DSK3SPTVN1PROD with NOTICES I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2015– 0102 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2015–0102. A copy of the collection of information and related instructions may be obtained without charge by accessing Docket ID NRC–2015–0102 on this Web site. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. A copy of the collection of information and related instructions may be obtained without charge by accessing ADAMS Accession No. ML15209A593. The supporting statement available in ADAMS under Accession No. ML15209A605. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting NRC’s Clearance Officer, Tremaine Donnell, Office of Information Services, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 6258; email: INFOCOLLECTS.Resource@ NRC.GOV. B. Submitting Comments The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your VerDate Sep<11>2014 17:30 Sep 16, 2015 Jkt 235001 comment submission. All comment submissions are posted at https:// www.regulations.gov and entered into ADAMS. Comment submissions are not routinely edited to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that comment submissions are not routinely edited to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the NRC recently submitted a proposed collection of information to OMB for review entitled, ‘‘Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than Conventional Residences Receiving Such Patients.’’ The NRC hereby informs potential responses that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on Tuesday, May 19, 2015 (80 FR 28715). 1. The title of the information collection: Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than Conventional Residences Receiving Such Patients. 2. OMB approval number: An OMB control number has not yet been assigned to this proposed information collection. 3. Type of submission: New. 4. The form number, if applicable: N/ A. 5. How often the collection is required or requested: One-time. 6. Who will be required or asked to respond: Institutions that treat thyroid cancer patients with I–131 and the thyroid cancer patients who have been treated. 7. The estimated number of annual responses: 5,175 (175 for treating institutions and 5000 for individuals). 8. The estimated number of annual respondents: 5,175. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 9. The estimated number of hours needed annually to comply with the information collection requirement or request: 1,675 (175 hours for treating institution and 1500 hours for individuals). 10. Abstract: Although most patients return to their home after receiving diagnostic or therapeutic of Iodine-131, some patients released by the licensee may stay at another location (such as a hotel) for a few days. However, the extent of this practice is unclear. The same uncertainty exists regarding patients returning to nursing homes and other institutional settings. Therefore, one of the main objectives of this study is to obtain reliable statistical data that provides good estimates of the prevalence of these practices. The second objective is to determine, by measurements, the external and internal doses received by members of the general public at hotels, nursing homes, or other institutional settings that receive treated patients immediately after their release. Dated at Rockville, Maryland, this 14th day of September, 2015. For the Nuclear Regulatory Commission. Tremaine Donnell, NRC Clearance Officer, Office of Information Services. [FR Doc. 2015–23367 Filed 9–16–15; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2015–0214] Independent Assessment of Nuclear Material Control and Accounting Systems Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft regulatory guide (DG), DG–5049, ‘‘Independent Assessment of Nuclear Material Control and Accounting Systems.’’ This DG provides guidance from experience gained since the regulatory guide was initially published in June 1975. In particular, the guidance for performing independent assessments has been expanded to include process monitoring and item monitoring for Category I fuel cycle facilities, and to include guidance for uranium enrichment facilities. In addition, this revision addresses changes in Material Control & Accounting (MC&A) terminology; for SUMMARY: E:\FR\FM\17SEN1.SGM 17SEN1

Agencies

[Federal Register Volume 80, Number 180 (Thursday, September 17, 2015)]
[Notices]
[Pages 55879-55880]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23367]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2015-0102]


Information Collection: Destinations of Released Patients 
Following Treatment with Iodine-131 and Estimation of Doses to Members 
of the Public at Locations Other Than Conventional Residences Receiving 
Such Patients

AGENCY: Nuclear Regulatory Commission.

ACTION: Proposed information collection: request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a proposed collection of information to the Office of 
Management and Budget (OMB) for review. The information collection is 
entitled, ``Destinations of Released Patients Following Treatment with 
Iodine-131 and Estimation of Doses to Members of the Public at 
Locations other than Conventional Residences Receiving Such Patients.''

DATES: Submit comments by October 19, 2015.

ADDRESSES: Submit comments directly to OMB reviewer at: Vlad Dorjets, 
Desk Officer, Office of Information and Regulatory Affairs (3150-XXXX), 
NEOB-10202, Office of Management and Budget, Washington, DC 20503;

[[Page 55880]]

telephone: 202-395-7315, email: oira_submission@omb.eop.gov.

FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
INFOCOLLECTS.Resource@NRC.GOV.

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2015-0102 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2015-0102. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2015-0102 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. A 
copy of the collection of information and related instructions may be 
obtained without charge by accessing ADAMS Accession No. ML15209A593. 
The supporting statement available in ADAMS under Accession No. 
ML15209A605.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting NRC's Clearance Officer, Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
INFOCOLLECTS.Resource@NRC.GOV.

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not want to be publicly 
disclosed in your comment submission. All comment submissions are 
posted at https://www.regulations.gov and entered into ADAMS. Comment 
submissions are not routinely edited to remove identifying or contact 
information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. Chapter 35), the NRC recently submitted a proposed collection of 
information to OMB for review entitled, ``Destinations of Released 
Patients Following Treatment with Iodine-131 and Estimation of Doses to 
Members of the Public at Locations other than Conventional Residences 
Receiving Such Patients.'' The NRC hereby informs potential responses 
that an agency may not conduct or sponsor, and that a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on Tuesday, May 19, 2015 (80 FR 
28715).
    1. The title of the information collection: Destinations of 
Released Patients Following Treatment with Iodine-131 and Estimation of 
Doses to Members of the Public at Locations other than Conventional 
Residences Receiving Such Patients.
    2. OMB approval number: An OMB control number has not yet been 
assigned to this proposed information collection.
    3. Type of submission: New.
    4. The form number, if applicable: N/A.
    5. How often the collection is required or requested: One-time.
    6. Who will be required or asked to respond: Institutions that 
treat thyroid cancer patients with I-131 and the thyroid cancer 
patients who have been treated.
    7. The estimated number of annual responses: 5,175 (175 for 
treating institutions and 5000 for individuals).
    8. The estimated number of annual respondents: 5,175.
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 1,675 (175 hours for 
treating institution and 1500 hours for individuals).
    10. Abstract: Although most patients return to their home after 
receiving diagnostic or therapeutic of Iodine-131, some patients 
released by the licensee may stay at another location (such as a hotel) 
for a few days. However, the extent of this practice is unclear. The 
same uncertainty exists regarding patients returning to nursing homes 
and other institutional settings. Therefore, one of the main objectives 
of this study is to obtain reliable statistical data that provides good 
estimates of the prevalence of these practices. The second objective is 
to determine, by measurements, the external and internal doses received 
by members of the general public at hotels, nursing homes, or other 
institutional settings that receive treated patients immediately after 
their release.

    Dated at Rockville, Maryland, this 14th day of September, 2015.

    For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-23367 Filed 9-16-15; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.